Depression treatment with Spravato represents a breakthrough for patients who haven’t found relief with standard antidepressants. If you’ve tried multiple medications without success, you’re not alone-and there’s a real option available.
At East Texas Psychiatry in Tyler, TX, we offer esketamine treatment for people struggling with treatment-resistant depression. This article explains how Spravato works and why it’s changing outcomes for our patients.
Why Standard Antidepressants Don’t Work for Everyone
The Serotonin Trap
Most antidepressants work by increasing serotonin or norepinephrine availability in the brain. SSRIs and SNRIs flood synapses with these neurotransmitters, which sounds straightforward until you realize that roughly 30 percent of patients with major depressive disorder fail to respond adequately after trying two or more antidepressants, according to research published in Pharmacy & Therapeutics. That’s not a small number-it’s millions of Americans stuck in a cycle of medication trials, dosage adjustments, and waiting weeks to see if the next pill works. The standard timeline is brutal: each antidepressant requires 4 to 8 weeks before you know whether it’s effective, which means a person trying three medications could spend half a year in active depression while their brain supposedly adjusts.
In Texas, where rural areas face severe psychiatric provider shortages, accessing even that standard care often means months on waiting lists. Treatment-resistant depression isn’t rare, and it isn’t a personal failure-it’s a biological reality that conventional serotonin-based approaches simply cannot address in roughly one-third of people who need help most.
Different Brains, Different Pathways
When antidepressants fail, the problem isn’t weak willpower or insufficient therapy. Some brains don’t respond to serotonin-boosting mechanisms because their depression involves different neurochemical pathways entirely. The glutamate system, which regulates excitatory neurotransmission and synaptic plasticity, appears central in these resistant cases. Traditional medications ignore this pathway altogether, which explains why increasing serotonin 40 times over produces zero symptom relief in certain patients. Depression that persists despite adequate medication trials correlates with specific patterns of neural circuit dysfunction that serotonergic drugs were never designed to fix.
The Mounting Cost of Waiting
Each failed medication trial costs time and suffering. The World Health Organization identifies depression as the leading cause of disability globally, and untreated depression drives approximately 800,000 suicides annually worldwide. In Tyler, TX and across Texas, suicide rates have climbed steadily, and delayed effective treatment directly increases risk. A person cycling through ineffective medications isn’t waiting passively-they’re experiencing worsening functional impairment, relationship deterioration, job loss, and accumulating hopelessness. The economic burden compounds too: each month of untreated or inadequately treated depression costs employers productivity, healthcare systems resources, and individuals their stability.
When a treatment exists that works through entirely different mechanisms and produces measurable improvement within days rather than weeks, continuing to pursue standard approaches becomes not just inefficient but potentially harmful. This reality sets the stage for understanding how esketamine operates and why it represents a fundamentally different path forward for people who have exhausted conventional options. If you’re struggling with depression that hasn’t responded to standard treatments, East Texas Psychiatry is here to help you explore evidence-based alternatives and live your best life.
How Esketamine Rewires Depression at the Cellular Level
A Fundamentally Different Mechanism
Esketamine operates through an entirely different pathway than the antidepressants you’ve likely already tried. Instead of increasing serotonin availability, esketamine blocks NMDA receptors on glutamate neurons, which triggers a cascade of downstream effects that actually rewires the brain’s mood circuitry. This glutamatergic approach activates AMPA signaling pathways and stimulates brain-derived neurotrophic factor production, essentially promoting rapid synaptic growth and reconnection in areas responsible for mood regulation. The practical result: measurable improvement in depression symptoms within 24 hours to a few days rather than weeks.
Speed Changes Everything
In the TRANSFORM-2 trial, patients receiving esketamine plus an oral antidepressant showed significant depression score improvements by day 28 on the MADRS scale. That speed matters enormously when you’re suffering. Each additional week of untreated depression increases suicide risk and deepens the cascade of life disruption-job performance deteriorates, relationships strain, and hopelessness compounds. Esketamine’s rapid action interrupts this downward spiral while your oral antidepressant builds its slower effect over weeks.
What Happens During Treatment
An actual treatment session differs markedly from taking a pill at home. You’ll self-administer esketamine as a nasal spray in a specialized medical office under psychiatric provider supervision, not alone in your bathroom. The drug reaches peak plasma concentration within 20 to 40 minutes, and you’ll spend approximately two hours in a quiet recovery space while clinical staff monitor your vital signs and symptom response. Common experiences during this window include dissociation (feeling detached from your body or surroundings), dizziness, and temporary blood pressure elevation-these effects are expected, monitored, and typically resolve within 90 minutes to two hours after dosing.
The Treatment Schedule and Long-Term Outcomes
The induction phase involves two treatment sessions weekly for four weeks, then transitions to maintenance dosing of once weekly or every other week depending on your response. You cannot drive home the same day, which means arranging transportation beforehand is non-negotiable.
The SUSTAIN-1 maintenance trial demonstrated that continuing esketamine significantly delayed relapse compared to placebo, with a 51 percent risk reduction for symptom recurrence. This isn’t a quick fix that wears off-it establishes durable improvement when combined with ongoing oral antidepressant therapy and, ideally, psychotherapy to address underlying patterns and build lasting resilience.
Understanding how esketamine works at the cellular level and what the treatment process actually involves prepares you for the next critical step: learning about the specialized infrastructure and clinical expertise required to administer this treatment safely and effectively.
SPRAVATO® Treatment at East Texas Psychiatry
Why Specialized Infrastructure Matters
Esketamine treatment demands infrastructure and expertise that most psychiatric practices simply don’t possess. The REMS program exists because esketamine carries real risks-dissociation, blood pressure elevation, and sedation-that require immediate medical oversight rather than self-management at home. Practices without REMS certification cannot legally administer this medication, which immediately eliminates the vast majority of psychiatric offices from offering it. We at East Texas Psychiatry maintain REMS certification specifically for SPRAVATO® administration, meaning we’ve invested in the clinical systems, staff training, and monitoring protocols required to deliver this treatment safely.
Your Initial Consultation and Assessment
Your first appointment includes a comprehensive consultation where our psychiatric providers assess your medication history, review prior treatment attempts, and verify insurance coverage. This isn’t a 15-minute intake-we conduct thorough evaluations that establish whether esketamine makes clinical sense for your specific situation. Our staff handles prior authorization directly, eliminating the administrative burden you’d face navigating insurance requirements alone. Many insurance plans cover SPRAVATO®, and we work with your coverage to minimize out-of-pocket costs.
The Treatment Process in Tyler, TX
During induction, you’ll attend sessions twice weekly for four weeks in a quiet, specialized treatment room designed for comfort and safety. You self-administer the nasal spray under direct psychiatric provider supervision, then remain in our facility for two hours of monitoring while clinical staff track vital signs, assess dissociation severity, and confirm symptom response. This observation period isn’t optional-it’s mandated by the FDA and reflects the medication’s pharmacology. You cannot drive yourself home, which means arranging transportation beforehand is non-negotiable; many patients arrange rides with family members or use services like Uber or Lyft, scheduling pickup 2.5 hours after arrival.
Maintenance and Long-Term Stability
Once you stabilize during induction, maintenance typically transitions to weekly or every-other-week dosing, dramatically reducing the time commitment while maintaining symptom improvement. Critically, esketamine works alongside an oral antidepressant, not instead of one-our integrated care model pairs medication management with evidence-based psychotherapy including Cognitive Behavioral Therapy and trauma-focused interventions delivered by licensed therapists collaborating directly with psychiatric providers. This combination addresses both neurochemistry and behavioral patterns simultaneously. The SUSTAIN-1 trial demonstrated that patients continuing esketamine maintenance showed a 51 percent reduction in relapse risk compared to placebo, meaning the improvement you achieve during induction stabilizes with ongoing treatment rather than evaporating once sessions end.
Final Thoughts
Treatment-resistant depression doesn’t have to be permanent. If you’ve exhausted standard antidepressants and watched months disappear waiting for medications that never worked, depression treatment with Spravato offers a genuinely different path forward. The evidence is clear: esketamine produces measurable improvement within days rather than weeks, and long-term maintenance prevents relapse in the majority of patients who respond to induction therapy.
At East Texas Psychiatry in Tyler, TX, we’ve built the specialized infrastructure and clinical expertise required to deliver this treatment safely and effectively. Our psychiatric providers maintain REMS certification specifically for Spravato administration, and our integrated care model pairs medication management with evidence-based psychotherapy delivered by licensed therapists collaborating with psychiatric providers. We handle insurance verification and prior authorization directly, eliminating administrative barriers that delay treatment elsewhere.
The next step is straightforward: schedule a comprehensive consultation with our team. During your initial evaluation, we’ll review your medication history, assess whether Spravato makes clinical sense for your specific situation, and discuss all available treatment options transparently. Visit East Texas Psychiatry today to schedule your evaluation and take the first step toward lasting recovery.
Ready to Take the Next Step?
If you’re struggling with depression, anxiety, or other mental health challenges, you don’t have to face it alone. East Texas Psychiatry and Counseling offers same-week appointments, evidence-based treatment, and breakthrough options like SPRAVATO® therapy for treatment-resistant depression.
Our board-certified psychiatric providers serve Tyler, Longview, and communities throughout East Texas via convenient in-person and telepsychiatry appointments.
Call us today at (430) 288-5800 or schedule your consultation online.
We accept most major insurance plans including Medicare. Let us help you reclaim joy, restore functioning, and rediscover your potential.
